akhatri

The Government is yet to conclude consideration of any increases to prescription charges and NHS prescription pre-payment certificates (PPCs) for 2025/26. Therefore, the current charges will roll over into May 2025. Community Pharmacy England will update community pharmacy teams as soon as any changes are announced by Ministers, including details of when they will be [...]

The post £9.90 NHS prescription and PPC charges unchanged for May 2025 appeared first on Community Pharmacy England.

NHS England (NHSE) has confirmed that all remaining supplies of Government procured COVID-19 antiviral medicine Paxlovid® (Nirmatrelvir 150mg tablets and Ritonavir 100mg tablets) will expire on 31 May 2025. This follows the recent deletion of Lagevrio® (Molnupiravir 200mg capsules) from Part VIIIC of the April 2025 Drug Tariff after Government stock of Lagevrio® expired on [...]

The post Expiry of Government stockpile of Paxlovid® (Nirmatrelvir 150mg tablets and Ritonavir 100mg tablets) appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Notification: Lercanidipine HCl 20mg Tablets (Recordati Industria) Drug alert number: EL(25)A/17 Date issued: 17 April 2025 Recordati Pharmaceuticals Limited has informed the MHRA of an error in the strength of the product printed on some of the faces (sides) of the product carton. The error is limited to one batch of [...]

The post MHRA Class 2 Medicines Recall: Lercanidipine HCl 20mg Tablets (Recordati Industria) appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Notification: Synalar GEL 30g, Synalar GEL 60g,(fluocinoline acetonide 0.025%) Reig Jofre UK Drug alert number: EL(25)A/16 Date issued: 08 April 2025 It has been identified that the batches of Synalar Gel 30g and 60g listed in this notification contain a residual solvent (benzene) at a level exceeding the ICH limit of [...]

The post MHRA Class 2 Medicines Recall: Synalar GEL 30g & Synalar GEL 60g, (fluocinoline acetonide 0.025%) Reig Jofre UK appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status as complete pack sizes from April 2025: Cetraxal® 2mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) Cetraxal® Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma [...]

The post Cetraxal® preparations – change to special container status from sub-pack to complete pack appeared first on Community Pharmacy England.